- Presentations
- 4
- Markets
- 1
Mydayis is a brand of Amphetamine and Dextroamphetamine marketed by Takeda Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Amphetamine and Dextroamphetamine
- Brand owner
- Takeda Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 12.5 mg/12.5 mg/12.5 mg/12.5 mg extended-release capsule, 3.125 mg/3.125 mg/3.125 mg/3.125 mg extended-release capsule, 6.25 mg/6.25 mg/6.25 mg/6.25 mg extended-release capsule, 9.375 mg/9.375 mg/9.375 mg/9.375 mg extended-release capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Mydayis 12.5 mg/12.5 mg/12.5 mg/12.5 mg extended-release capsuleOral | Takeda Pharmaceuticals | US FDA | Available on request |
| Mydayis 3.125 mg/3.125 mg/3.125 mg/3.125 mg extended-release capsuleOral | Takeda Pharmaceuticals | US FDA | Available on request |
| Mydayis 6.25 mg/6.25 mg/6.25 mg/6.25 mg extended-release capsuleOral | Takeda Pharmaceuticals | US FDA | Available on request |
| Mydayis 9.375 mg/9.375 mg/9.375 mg/9.375 mg extended-release capsuleOral | Takeda Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Amphetamine and Dextroamphetamine.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Mydayis
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.